bromocriptine has been researched along with Minimal Disease, Residual in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Greenman, Y; Osher, E; Ouaknine, G; Reider-Groswasser, II; Segev, Y; Shenkerman, G; Stern, N; Tordjman, K; Veshchev, I | 1 |
Benveniste, RJ; Delman, BN; King, WA; Lee, JS; Post, KD; Walsh, J | 1 |
Black, PM; Garber, JR; Glickman, JN; Lidov, HG; McCowen, KC; Zervas, NT | 1 |
3 other study(ies) available for bromocriptine and Minimal Disease, Residual
Article | Year |
---|---|
Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth.
Topics: Adenoma; Adult; Aged; Bromocriptine; Cohort Studies; Dopamine Agonists; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Pituitary Neoplasms; Postoperative Period; Survival Analysis; Thyrotropin-Releasing Hormone; Treatment Outcome | 2005 |
Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Bromocriptine; Child; Combined Modality Therapy; Female; Hormone Antagonists; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Neurosurgical Procedures; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Postoperative Complications; Predictive Value of Tests; Radiotherapy; Reoperation; Retrospective Studies; Sphenoid Bone; Treatment Outcome | 2005 |
Gangliocytoma masquerading as a prolactinoma. Case report.
Topics: Adult; Bromocriptine; Diagnosis, Differential; Follow-Up Studies; Ganglioneuroma; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Neoplasm, Residual; Neurofilament Proteins; Pituitary Neoplasms; Prolactin; Prolactinoma; Synaptophysin; Temporal Lobe | 1999 |